Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events in patients with and without preexisting atherosclerotic cardiovascular disease (ASCVD), a new study shows. The ...
Lipoprotein a — Lp(a) — is a new focus of interest as an independent cardiovascular (CV) risk factor, with several new drugs that lower this lipoprotein now on the horizon. Given that Lp(a) levels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results